Billing & Compliance Director
Department of Radiation Oncology, Kaufman Cancer Center, University of Maryland Upper Chesapeake Health, 500 Upper Chesapeake Dr., Bel Air, MD 21014
Education and Training
Radiation Oncology Residency
Emory University, 2019
Emory University, 2015
University of Maryland School of Medicine, 2014
Loyola University Maryland, 2010
Dr. Matthew J. Ferris is an Assistant Professor in the Department of Radiation Oncology at the University of Maryland. His primary practice locations include University of Maryland Upper Chesapeake Health, and the Maryland Proton Treatment Center. He has broad clinical interests that encompass treatment for most malignant and non-malignant tumors, and use of advanced radiation techniques.
Dr. Ferris grew up in Towson, MD. He completed his undergraduate studies in 2010 at Loyola University Maryland where he majored in Biology, with minors in Business and English, and graduated summa cum laude. He was elected a member of the Phi Beta Kappa Society. He graduated cum laude from the University of Maryland Medical School in 2014, and there was elected a member of the Alpha Omega Alpha Honor Medical Society.
In 2015 he completed a medical internship at Emory University in Atlanta, Georgia, and then he continued on at Emory to complete residency training in radiation oncology in 2019. He served as Chief Resident during his final year of training. During residency, he conducted clinical research in several areas including: cardiac-sparing radiation planning techniques such as cardiac-optimized volumetric modulated arc therapy and intensity modulated proton therapy, implications of radiation dose to the heart, and effects of radiation dose to the central nervous system on patient symptoms in head and neck cancer. Training at Emory provided broad clinical exposure and included high case volumes of stereotactic radiosurgery, stereotactic body radiation therapy, and high dose rate brachytherapy.
Dr. Ferris’ ongoing research at the University of Maryland is focused on optimizing advanced radiation techniques to maximize control of malignancies while sparing side effects and improving long-term patient reported outcomes. His research has resulted in numerous peer-reviewed publications and has yielded oral presentations at national and international conferences.
Overall, Dr. Ferris strives to work closely with the entire treatment team, including surgeon and medical oncology colleagues, to offer cutting edge and tailored treatment for each patient. One of his main focuses in his practice at UM Upper Chesapeake is to bring world-class cancer treatment options to the residents of Harford County. He prizes meticulousness and attention to detail throughout each patient’s course of radiation therapy.
In his spare time he enjoys surfing, golfing, hunting, and spending time with his wife and daughter.
General Radiation Oncology, External Beam Radiation, Volumetric Modulated Arc Therapy, 3D Conformal Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT), Stereotactic Radiosurgery (SRS), Proton Therapy, High Dose Rate Brachytherapy (skin, prostate, breast, gynecologic), Oligometastatic Disease
MJ Ferris, KS Martin, JM Switchenko, OA Kayode, J Wolf, Q Dang, RH Press, WJ Curran, and KA Higgins. Sparing cardiac substructures with optimized volumetric modulated arc therapy and intensity-modulated proton therapy in thoracic radiation for locally advanced non-small cell lung cancer. Practical Radiation Oncology 2019. E-pub ahead of print, April 2019. doi: https://doi.org/10.1016/j.prro.2019.04.013
MJ Ferris, Y Liu, J Ao, J Zhong, M Abugideiri, TW Gillespie, BC Carthon, MA Bilen, O Kucuk, and AB Jani. The addition of chemotherapy in the definitive management of high-risk prostate cancer. Urologic Oncology 2018; 36(11). doi: 10.1016/j.urolonc.2018.07.020
MJ Ferris, R Jiang, M Behera, S Ramalingam, WJ Curran, and KA Higgins. Radiation therapy is associated with an increase in incidence of cardiac events for patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys (Red Journal) 2018; 102: 383 – 390. doi: 10.1016/j.ijrobp.2018.05.066
MJ Ferris, J Zhong, JM Switchenko, KA Higgins, RJ Cassidy, MW McDonald, BR Eaton, KR Patel, CE Steuer, HM Baddour Jr, AH Miller, DW Bruner, C Xiao, and JJ Beitler. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiotherapy. Radiotherapy and Oncology (Green Journal) 2018; 126: 100-106. doi: 10.1016/j.radonc.2017.08.008